The Advanced Therapy Medicinal Products CDMO Market is positioned for remarkable expansion, projected to escalate from a market size of USD 29.97 billion in 2024 to USD 134.73 billion by 2035. This represents a compound annual growth rate (CAGR) of 14.64%, underscoring the increasing significance of contract development and manufacturing organizations (CDMOs) in the biopharmaceutical sector. As...